DOCSLIB.ORG

Product Sheet Info

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Product Sheet Info Product Information Sheet for NR-19556 Salmonella enterica subsp. enterica, Strain supplemented with 15% glycerol. ® Ty2 (Serovar Typhi), Gateway Clone Set, Packaging/Storage: Recombinant in Escherichia coli, Plate 35 NR-19556 was packaged aseptically in a 96-well plate. The product is provided frozen and should be stored at -80°C or Catalog No. NR-19556 colder immediately upon arrival. For long-term storage, the This reagent is the tangible property of the U.S. Government. vapor phase of a liquid nitrogen freezer is recommended. Freeze-thaw cycles should be avoided. For research use only. Not for human use. Growth Conditions: Media: Contributor: LB broth or agar containing 50 µg/mL kanamycin. Pathogen Functional Genomics Resource Center at the J. Incubation: Craig Venter Institute Temperature: 37°C Atmosphere: Aerobic Manufacturer: Propagation: BEI Resources 1. Scrape top of frozen well with a pipette tip and streak onto agar plate. Product Description: 2. Incubate the plates at 37°C for 24 hours. Clone plates are replicated using a BioMek® FX robot. Production in the 96-well format has increased risk of cross- Citation: contamination between adjacent wells. Individual clones Acknowledgment for publications should read “The following should be purified (e.g. single colony isolation and reagent was obtained through BEI Resources, NIAID, purification using good microbiological practices) and NIH: Salmonella enterica subsp. enterica, Strain Ty2 sequence-verified prior to use. BEI Resources only confirms (Serovar Typhi), Gateway® Clone Set, Recombinant in the clone plate orientation and viability of randomly picked Escherichia coli, Plate 35, NR-19556.” clones. BEI Resources does not confirm or validate individual clone identities provided by the contributor. Biosafety Level: 1 Appropriate safety procedures should always be used with The Salmonella enterica subsp. enterica (S. enterica subsp. this material. Laboratory safety is discussed in the following ® enterica), strain Ty2 (serovar Typhi), Gateway clone set publication: U.S. Department of Health and Human Services, consists of approximately 3380 sequence validated clones Public Health Service, Centers for Disease Control and from S. enterica subsp. enterica, strain Ty2, cloned in Prevention, and National Institutes of Health. Biosafety in Escherichia coli (E. coli) DH10B-T1 cells. Each open reading Microbiological and Biomedical Laboratories. 5th ed. frame was constructed in vector pDONR221 (Invitrogen) Washington, DC: U.S. Government Printing Office, 2009; see with an ATG start codon and no stop codon. The sequence www.cdc.gov/biosafety/publications/bmbl5/index.htm. was validated by full length sequencing of each clone with greater than 1X coverage and a mutation rate of less than Disclaimers: 0.2%. Detailed information about each clone is shown in You are authorized to use this product for research use only. Table 1. It is not intended for human use. ® Information related to the use of Gateway Clones can be Use of this product is subject to the terms and conditions of obtained from Invitrogen. Recombination was facilitated the BEI Resources Material Transfer Agreement (MTA). The through an attB substrate (attB-PCR product or a linearized MTA is available on our Web site at www.beiresources.org. attB expression clone) with an attP substrate (pDONR221) to create an attL-containing entry clone. The entry clone While BEI Resources uses reasonable efforts to include contains recombinational cloning sites, attL1 and attL2 to accurate and up-to-date information on this product sheet, facilitate gene transfer into a destination vector, M13 forward neither ATCC® nor the U.S. Government makes any and reverse priming sites for sequencing and a kanamycin warranties or representations as to its accuracy. Citations resistance gene for selection. Please refer to the Invitrogen from scientific literature and patents are provided for Gateway® Technology Manual for additional details. informational purposes only. Neither ATCC® nor the U.S. Government warrants that such information has been Plate orientation and viability were confirmed for NR-19556. confirmed to be accurate. Material Provided: This product is sent with the condition that you are Each inoculated well of the 96-well plate contains responsible for its safe storage, handling, use and disposal. approximately 60 µL of E. coli culture (strain DH10B-T1) in ATCC® and the U.S. Government are not liable for any Luria Bertani (LB) broth containing 50 µg/mL kanamycin damages or injuries arising from receipt and/or use of this BEI Resources E-mail: [email protected] www.beiresources.org Tel: 800-359-7370 Fax: 703-365-2898 © 2013 American Type Culture Collection (ATCC). All rights reserved. NR-19556_20NOV2013 Page 1 of 4 Product Information Sheet for NR-19556 product. While reasonable effort is made to ensure its derivatives must contact the contributor to determine if a authenticity and reliability of materials on deposit, the U.S. license is required. U.S. Government contractors may need Government, ATCC®, their suppliers and contributors to BEI a license before first commercial sale. Resources are not liable for damages arising from the misidentification or misrepresentation of products. References: 1. Deng, W., et al. “Comparative Genomics of Salmonella Use Restrictions: enterica serovar Typhi strains Ty2 and CT18.” J. This material is distributed for internal research, non- Bacteriol. 185 (2003): 2330-2337. PubMed: 12644504. commercial purposes only. This material, its product or its derivatives may not be distributed to third parties. Except as ATCC® is a trademark of the American Type Culture performed under a U.S. Government contract, individuals Collection. contemplating commercial use of the material, its products or Table 1: Salmonella enterica subsp. enterica, Strain Ty2 (Serovar Typhi), Gateway® Clone Set, Recombinant in Escherichia coli, Plate 35 (ZSTEI)1 Well ORF Accession Average Depth of Clone Locus ID Description Position Length Number Coverage 98935 A01 t3922 oligopeptidase A 2077 NP_807535.1 4.668272 98796 A02 t1282 secretion system apparatus protein SsaV 2080 NP_805085.1 3.225481 98823 A03 t1033 carboxy-terminal peptidase 2083 NP_804851.1 3.983677 98828 A04 t0998 protease 2 2086 NP_804821.1 4.786194 98907 A05 t3184 hypothetical protein t3184 2086 NP_806862.1 4.412752 99021 A06 t1845 DNA helicase IV 2089 NP_805614.1 3.235998 98729 A07 t0202 iron-hydroxamate transporter permease 2092 NP_804084.1 4.218451 98915 A08 t2784 pathogenicity island 1 effector protein 2092 NP_806485.1 4.027247 98843 A09 t2798 virulence-associated secretory protein 2092 NP_806499.1 3.723709 98927 A10 t3907 hypothetical protein t3907 2095 NP_807521.1 4.871122 98739 A11 t0356 polyphosphate kinase 2101 NP_804226.1 3.34793 98719 A12 t4168 type I secretion protein 2101 NP_807772.1 4.814374 98815 B01 t3864 glucyl-tRNA synthetase subunit beta 2104 NP_807483.1 4.411597 formate hydrogenlyase system 98971 B02 t2761 2113 NP_806462.1 4.539991 transcriptional activator 99007 B03 t3774 ATP-dependent DNA helicase RecG 2116 NP_807397.1 3.724953 99061 B04 t3993 4-alpha-glucanotransferase 2116 NP_807603.1 3.836011 98951 B05 t4260 hypothetical protein t4260 2125 NP_807858.1 4.312941 98835 B06 t4131 lipoprotein 2131 NP_807735.1 4.217738 98699 B07 t0018 chitinase 2134 NP_803903.1 4.116682 98879 B08 t2268 carbon starvation protein A 2140 NP_806010.1 4.149533 99024 B09 t0737 hypothetical protein t0737 2146 NP_804581.1 3.997204 bifunctional (p)ppGpp synthetase II/ 98957 B10 t3776 guanosine 3’,5’-bis pyrophosphate 3’- 2146 NP_807399.1 3.264212 pyrophosphohydrolase 98933 B11 t4059 elongation factor G 2149 NP_807666.1 4.167985 98919 B12 t1497 TonB-dependent receptor 2155 NP_805283.1 4.115081 98867 C01 t4011 hypothetical protein t4011 2167 NP_807621.1 3.187356 98851 C02 t3200 polynucleotide phosphorylase 2170 NP_806878.1 4.430415 anaerobic ribonucleoside triphosphate 98875 C03 t4486 2173 NP_808073.1 3.489646 reductase 98944 C04 t0236 lysine decarboxylase 2176 NP_804116.1 3.444853 multifunctional fatty acid oxidation 98695 C05 t0476 2182 NP_804334.1 3.569203 complex subunit alpha 98831 C06 t1505 virulence effector protein 2182 NP_805291.1 4.648029 98707 C07 t4192 formate dehydrogenase H 2182 NP_807796.1 4.415215 BEI Resources E-mail: [email protected] www.beiresources.org Tel: 800-359-7370 Fax: 703-365-2898 © 2013 American Type Culture Collection (ATCC). All rights reserved. NR-19556_20NOV2013 Page 2 of 4 Product Information Sheet for NR-19556 Well Locus ORF Accession Average Depth Clone Description Position ID Length Number of Coverage 98787 C08 t1847 hypothetical protein t1847 2188 NP_805616.1 4.686929 98999 C09 t0756 tyrosine kinase 2194 NP_804600.1 3.790793 bifunctional acyl-[acyl carrier protein] synthetase/2- 98848 C10 t2919 2194 NP_806613.1 3.137192 acylglycerophosphoethanolamine acyltransferase 98751 C11 t3346 DNA-dependent helicase II 2197 NP_807014.1 4.282658 99055 C12 t3088 hypothetical protein t3088 2206 NP_806772.1 3.586582 98811 D01 t3982 glycogen branching protein 2221 NP_807592.1 4.298964 multifunctional fatty acid oxidation 98820 D02 t3315 2224 NP_806983.1 1.957734 complex subunit alpha zinc/cadmium/mercury/lead-transporting 98723 D03 t3946 2233 NP_807557.1 3.521272 ATPase 98735 D04 t2845 hypothetical protein t2845 2242 NP_806542.1 4.4157 98779 D05 t0354 hypothetical protein t0354 2248 NP_804224.1 4.516904 98979 D06 t2061 hypothetical protein t2061 2257 NP_805824.1 4.32521 98711 D07 t2744 hydrogenase maturation protein 2275 NP_806445.1
Load more

Recommended publications
  • Enzymatic Encoding Methods for Efficient Synthesis Of
    (19) TZZ__T (11) EP 1 957 644 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: C12N 15/10 (2006.01) C12Q 1/68 (2006.01) 01.12.2010 Bulletin 2010/48 C40B 40/06 (2006.01) C40B 50/06 (2006.01) (21) Application number: 06818144.5 (86) International application number: PCT/DK2006/000685 (22) Date of filing: 01.12.2006 (87) International publication number: WO 2007/062664 (07.06.2007 Gazette 2007/23) (54) ENZYMATIC ENCODING METHODS FOR EFFICIENT SYNTHESIS OF LARGE LIBRARIES ENZYMVERMITTELNDE KODIERUNGSMETHODEN FÜR EINE EFFIZIENTE SYNTHESE VON GROSSEN BIBLIOTHEKEN PROCEDES DE CODAGE ENZYMATIQUE DESTINES A LA SYNTHESE EFFICACE DE BIBLIOTHEQUES IMPORTANTES (84) Designated Contracting States: • GOLDBECH, Anne AT BE BG CH CY CZ DE DK EE ES FI FR GB GR DK-2200 Copenhagen N (DK) HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI • DE LEON, Daen SK TR DK-2300 Copenhagen S (DK) Designated Extension States: • KALDOR, Ditte Kievsmose AL BA HR MK RS DK-2880 Bagsvaerd (DK) • SLØK, Frank Abilgaard (30) Priority: 01.12.2005 DK 200501704 DK-3450 Allerød (DK) 02.12.2005 US 741490 P • HUSEMOEN, Birgitte Nystrup DK-2500 Valby (DK) (43) Date of publication of application: • DOLBERG, Johannes 20.08.2008 Bulletin 2008/34 DK-1674 Copenhagen V (DK) • JENSEN, Kim Birkebæk (73) Proprietor: Nuevolution A/S DK-2610 Rødovre (DK) 2100 Copenhagen 0 (DK) • PETERSEN, Lene DK-2100 Copenhagen Ø (DK) (72) Inventors: • NØRREGAARD-MADSEN, Mads • FRANCH, Thomas DK-3460 Birkerød (DK) DK-3070 Snekkersten (DK) • GODSKESEN,
    [Show full text]
  • Marine Organisms: a Source of Biomedically Relevant Metallo M1
    Marine organisms : a source of biomedically relevant metallo M1, M2 and M17 exopeptidase inhibitors Isel Pascual Alonso, Laura Rivera Méndez, Fabiola Almeida, Mario Ernesto Valdés Tresano, Yarini Arrebola Sánchez, Aida Hernández-Zanuy, Luis Álvarez-Lajonchere, Dagmara Díaz, Belinda Sánchez, Isabelle Florent, et al. To cite this version: Isel Pascual Alonso, Laura Rivera Méndez, Fabiola Almeida, Mario Ernesto Valdés Tresano, Yarini Arrebola Sánchez, et al.. Marine organisms : a source of biomedically relevant metallo M1, M2 and M17 exopeptidase inhibitors. REVISTA CUBANA DE CIENCIAS BIOLÓGICAS, 2020, 8 (2), pp.1- 36. hal-02944434 HAL Id: hal-02944434 https://hal.archives-ouvertes.fr/hal-02944434 Submitted on 21 Sep 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. REVISTA CUBANA DE CIENCIAS BIOLÓGICAS http://www.rccb.uh.cu ARTÍCULO DE REVISIÓN Marine organisms: a source of biomedically relevant metallo M1, M2 and M17 exopeptidase inhibitors Los organismos marinos: Fuente de inhibidores de exopeptidasas de tipo metalo M1, M2 y M17 de relevancia biomédica Isel Pascual Alonso1 , Laura Rivera Méndez1 , Fabiola Almeida1 , Mario Ernesto Valdés Tresanco1,2 , Yarini Arrebola Sánchez1 , Aida Hernández-Zanuy3 , Luis Álvarez-Lajonchere4 , Dagmara Díaz1 , Belinda Sánchez5 , Isabelle Florent6 , Marjorie Schmitt7 , Miguel Cisneros8 , Jean Louis Charli8 1 Center for Protein Studies, Faculty of ABSTRACT Biology, University of Havana, Cuba.
    [Show full text]
  • Dottorato Di Ricerca International Doctorate in Structural Biology
    DOTTORATO DI RICERCA INTERNATIONAL DOCTORATE IN STRUCTURAL BIOLOGY CICLO XXVII COORDINATORE Prof. Claudio Luchinat NEW COMPUTATIONAL APPROACHES TO THE STUDY OF METALS IN BIOLOGY Settore Scientifico Disciplinare CHIM/03 Dottorando Tutore Dott.ssa Yana Valasatava Dr. Claudia Andreini _______________________________ _____________________________ Coordinatore Prof. Claudio Luchinat _______________________________ Anni 2012/2014 This thesis has been approved by the University of Florence, the University of Frankfurt and the Utrecht University Acknowledgments Doing a PhD is a challenging enterprise, and I would like to thank all the people who provided me help and support along this journey. First and foremost, thanks must go to the members of my research group. I was fortunate to work and study in a very friendly, spirited and productive team. I can no longer estimate the number of points in the process of research when their comments led to significant improvements of the project and choosing more meaningful directions. Their influence on my life was profound, and I thank them deeply. Most importantly, I’m thankful to my supervisor Dr. Claudia Andreini for giving me the chance to work on this project, for sharing her limitless enthusiasm about the fascinating world of metalloproteins, for giving me freedom but never leaving without a piece of a good advice. I am especially grateful to Prof. Antonio Rosato for his patience, fruitful discussions, constructive critique and providing additional supervision along the way. His endless knowledge, experience, and determination were crucial ingredients that made this work possible. I would also like to acknowledge the help of Dr. Gabriele Cavallaro and express my regret at not being able to work together longer.
    [Show full text]
  • Specific Aminopeptidases of Indigenous Lactobacillus Brevis and Lactobacillus Plantarum
    African Journal of Biotechnology Vol. 11(88), pp. 15438-15445, 1 November, 2012 Available online at http://www.academicjournals.org/AJB DOI: 10.5897/AJB12.703 ISSN 1684–5315 ©2012 Academic Journals Full Length Research Paper Specific aminopeptidases of indigenous Lactobacillus brevis and Lactobacillus plantarum BELKHEIR Khadidja*, ROUDJ Salima, ZADI KARAM Halima and KARAM Nour Eddine Laboratoire de Biologie des Microorganismes et Biotechnologie (LBMB). Université d’Oran, Algérie. Accepted 5 September, 2012 Lactic acid bacteria play an important role in milk coagulation and cheese ripening. To select strains showing interesting industrial features, two indigenous lactobacilli (Lactobacillus brevis and Lactobacillus plantarum) were studied for aminopeptidase activity. Cell and cells free extract were tested for leucyl aminopeptidase activity on the chromogenic leucyl-p-nitroanilide substrate. Intracellu- lar and membrane enzymes were solubilized with glycine /lyzozyme treatment then purified by ammonium sulphate precipitation followed by Sephadex G100 and diethylaminoethyl (DEAE) ions exchange chromatography’s separation. The molecular weight of denatured proteins was estimated on sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS PAGE). Effects of several parameters, pH, temperature, some ions and inhibitors on purified enzyme activity were studied. Cellular amino- peptidase activity was higher for CHTD 27 strain than BH14 strain. No aminopeptidase activity was noted in the cell free extract. The results of chromatography sephadex G100 combined to those of electrophoresis allowed suggesting a dimer structure for the native enzyme. The Lb CHTD27 purified enzyme showed maximal activity at pH 6.6 and at 40°C. This enzyme was partially inhibited by ethylenediamine acetic acid (EDTA) and Cu2+ ions but increased by Na2+ and Co2+ ions.
    [Show full text]
  • Studies of Structure and Function of Tripeptidyl-Peptidase II
    Till familj och vänner List of Papers This thesis is based on the following papers, which are referred to in the text by their Roman numerals. I. Eriksson, S.; Gutiérrez, O.A.; Bjerling, P.; Tomkinson, B. (2009) De- velopment, evaluation and application of tripeptidyl-peptidase II se- quence signatures. Archives of Biochemistry and Biophysics, 484(1):39-45 II. Lindås, A-C.; Eriksson, S.; Josza, E.; Tomkinson, B. (2008) Investiga- tion of a role for Glu-331 and Glu-305 in substrate binding of tripepti- dyl-peptidase II. Biochimica et Biophysica Acta, 1784(12):1899-1907 III. Eklund, S.; Lindås, A-C.; Hamnevik, E.; Widersten, M.; Tomkinson, B. Inter-species variation in the pH dependence of tripeptidyl- peptidase II. Manuscript IV. Eklund, S.; Kalbacher, H.; Tomkinson, B. Characterization of the endopeptidase activity of tripeptidyl-peptidase II. Manuscript Paper I and II were published under maiden name (Eriksson). Reprints were made with permission from the respective publishers. Contents Introduction ..................................................................................................... 9 Enzymes ..................................................................................................... 9 Enzymes and pH dependence .............................................................. 11 Peptidases ................................................................................................. 12 Serine peptidases ................................................................................. 14 Intracellular protein
    [Show full text]
  • Handbook of Proteolytic Enzymes Second Edition Volume 1 Aspartic and Metallo Peptidases
    Handbook of Proteolytic Enzymes Second Edition Volume 1 Aspartic and Metallo Peptidases Alan J. Barrett Neil D. Rawlings J. Fred Woessner Editor biographies xxi Contributors xxiii Preface xxxi Introduction ' Abbreviations xxxvii ASPARTIC PEPTIDASES Introduction 1 Aspartic peptidases and their clans 3 2 Catalytic pathway of aspartic peptidases 12 Clan AA Family Al 3 Pepsin A 19 4 Pepsin B 28 5 Chymosin 29 6 Cathepsin E 33 7 Gastricsin 38 8 Cathepsin D 43 9 Napsin A 52 10 Renin 54 11 Mouse submandibular renin 62 12 Memapsin 1 64 13 Memapsin 2 66 14 Plasmepsins 70 15 Plasmepsin II 73 16 Tick heme-binding aspartic proteinase 76 17 Phytepsin 77 18 Nepenthesin 85 19 Saccharopepsin 87 20 Neurosporapepsin 90 21 Acrocylindropepsin 9 1 22 Aspergillopepsin I 92 23 Penicillopepsin 99 24 Endothiapepsin 104 25 Rhizopuspepsin 108 26 Mucorpepsin 11 1 27 Polyporopepsin 113 28 Candidapepsin 115 29 Candiparapsin 120 30 Canditropsin 123 31 Syncephapepsin 125 32 Barrierpepsin 126 33 Yapsin 1 128 34 Yapsin 2 132 35 Yapsin A 133 36 Pregnancy-associated glycoproteins 135 37 Pepsin F 137 38 Rhodotorulapepsin 139 39 Cladosporopepsin 140 40 Pycnoporopepsin 141 Family A2 and others 41 Human immunodeficiency virus 1 retropepsin 144 42 Human immunodeficiency virus 2 retropepsin 154 43 Simian immunodeficiency virus retropepsin 158 44 Equine infectious anemia virus retropepsin 160 45 Rous sarcoma virus retropepsin and avian myeloblastosis virus retropepsin 163 46 Human T-cell leukemia virus type I (HTLV-I) retropepsin 166 47 Bovine leukemia virus retropepsin 169 48
    [Show full text]
  • A Genomic Analysis of Rat Proteases and Protease Inhibitors
    A genomic analysis of rat proteases and protease inhibitors Xose S. Puente and Carlos López-Otín Departamento de Bioquímica y Biología Molecular, Facultad de Medicina, Instituto Universitario de Oncología, Universidad de Oviedo, 33006-Oviedo, Spain Send correspondence to: Carlos López-Otín Departamento de Bioquímica y Biología Molecular Facultad de Medicina, Universidad de Oviedo 33006 Oviedo-SPAIN Tel. 34-985-104201; Fax: 34-985-103564 E-mail: [email protected] Proteases perform fundamental roles in multiple biological processes and are associated with a growing number of pathological conditions that involve abnormal or deficient functions of these enzymes. The availability of the rat genome sequence has opened the possibility to perform a global analysis of the complete protease repertoire or degradome of this model organism. The rat degradome consists of at least 626 proteases and homologs, which are distributed into five catalytic classes: 24 aspartic, 160 cysteine, 192 metallo, 221 serine, and 29 threonine proteases. Overall, this distribution is similar to that of the mouse degradome, but significatively more complex than that corresponding to the human degradome composed of 561 proteases and homologs. This increased complexity of the rat protease complement mainly derives from the expansion of several gene families including placental cathepsins, testases, kallikreins and hematopoietic serine proteases, involved in reproductive or immunological functions. These protease families have also evolved differently in the rat and mouse genomes and may contribute to explain some functional differences between these two closely related species. Likewise, genomic analysis of rat protease inhibitors has shown some differences with the mouse protease inhibitor complement and the marked expansion of families of cysteine and serine protease inhibitors in rat and mouse with respect to human.
    [Show full text]
  • The Major Leucyl Aminopeptidase of Trypanosoma Cruzi (Laptc) Assembles Into a Homohexamer and Belongs to the M17 Family of Metal
    Cadavid-Restrepo et al. BMC Biochemistry 2011, 12:46 http://www.biomedcentral.com/1471-2091/12/46 RESEARCH ARTICLE Open Access The major leucyl aminopeptidase of Trypanosoma cruzi (LAPTc) assembles into a homohexamer and belongs to the M17 family of metallopeptidases Gloria Cadavid-Restrepo1,2†, Thiago S Gastardelo1†, Eric Faudry3,4,5, Hugo de Almeida1, Izabela MD Bastos6, Raquel S Negreiros1, Meire M Lima1, Teresa C Assumpção1,7, Keyla C Almeida1, Michel Ragno3,4,5, Christine Ebel5,8,9 , Bergmann M Ribeiro1, Carlos R Felix1 and Jaime M Santana1* Abstract Background: Pathogens depend on peptidase activities to accomplish many physiological processes, including interaction with their hosts, highlighting parasitic peptidases as potential drug targets. In this study, a major leucyl aminopeptidolytic activity was identified in Trypanosoma cruzi, the aetiological agent of Chagas disease. Results: The enzyme was isolated from epimastigote forms of the parasite by a two-step chromatographic procedure and associated with a single 330-kDa homohexameric protein as determined by sedimentation velocity and light scattering experiments. Peptide mass fingerprinting identified the enzyme as the predicted T. cruzi aminopeptidase EAN97960. Molecular and enzymatic analysis indicated that this leucyl aminopeptidase of T. cruzi (LAPTc) belongs to the peptidase family M17 or leucyl aminopeptidase family. LAPTc has a strong dependence on neutral pH, is mesophilic and retains its oligomeric form up to 80°C. Conversely, its recombinant form is thermophilic and requires alkaline pH. Conclusions: LAPTc is a 330-kDa homohexameric metalloaminopeptidase expressed by all T. cruzi forms and mediates the major parasite leucyl aminopeptidolytic activity. Since biosynthetic pathways for essential amino acids, including leucine, are lacking in T.
    [Show full text]
  • The Metalloaminopeptidases from Plasmodium Falciparum
    Available online at www.sciencedirect.com Working in concert: the metalloaminopeptidases from Plasmodium falciparum Sheena McGowan Malaria remains the world’s most prevalent human parasitic Parasites of the genus Plasmodium are the causative agents disease. Because of the rapid spread of drug resistance in of malaria. While four Plasmodium species commonly infect parasites, there is an urgent need to identify diverse new drug humans, Plasmodium falciparum (Pf) causes the most targets. One group of proteases that are emerging as targets deaths [3–5]. To date, nine MAPs have been identified for novel antimalarials are the metalloaminopeptidases. These in Pf (3D7) [6]. Four of these are methionine aminopepti- enzymes catalyze the removal of the N-terminal amino acids dases. The other five enzymes comprise a prolyl imino- 2 from proteins and peptides. Given the restricted specificities of peptidase (or post-prolyl aminopeptidase), a prolyl each of these enzymes for different N-terminal amino acids, it is aminopeptidase (see footnote 2), a leucine aminopepti- thought that they act in concert to facilitate protein turnover. dase, an alanine aminopeptidase and an aspartyl amino- Here we review recent structure and functional data relating to peptidase. Given the restricted specificities of each of the development of the Plasmodium falciparum these enzymes for particular N-terminal amino acids, it metalloaminopeptidases as drug targets is thought that they act in concert to facilitate hemoglobin Addresses (Hb) catabolism [7,8], a process essential to the survival of Department of Biochemistry and Molecular Biology, Monash University, Pf. However, recent studies show that the PfMAPs may Clayton Campus, Melbourne, Victoria 3800, Australia have additional roles to that of Hb digestion, including important housekeeping functions and in conjunction with Corresponding author: McGowan, Sheena ([email protected]) the parasite proteosome [9 ,10].
    [Show full text]
  • Proline Residues in the Maturation and Degradation of Peptide Hormones and Neuropeptides
    CORE Metadata, citation and similar papers at core.ac.uk Provided by Elsevier - Publisher Connector Volume 234, number 2, 251-256 FEB 06071 July 1988 Review Letter Proline residues in the maturation and degradation of peptide hormones and neuropeptides Rolf Mentlein Anatomisches Institut der Christian-Albrechts Universitiit zu Kiel, OlshausenstraJe 40.2300 Kiel I, FRG Received 4 May 1988; revised version received 23 May 1988 The proteases involved in the maturation of regulatory peptides like those of broader specificity normally fail to cleave peptide bonds linked to the cyclic amino acid proline. This generates several mature peptides with N-terminal X-Pro- sequences. However, in certain non-mammalian tissues repetitive pre-sequences of this type are removed by specialized dipeptidyl (amino)peptidases during maturation. In mammals, proline-specific proteases are not involved in the biosyn- thesis of regulatory peptides, but due to their unique specificity they could play an important role in the degradation of them. Evidence exists that dipeptidyl (amino)peptidase IV at the cell surface of endothelial cells sequesters circulating peptide hormones which arc then susceptible to broader aminopeptidase attack. The cleavage of several neuropeptides by prolyl endopeptidase has been demonstrated in vitro, but its role in the brain is questionable since the precise localiza- tion of the protease is not clarified. Neuropeptide; Peptide hormone; Proteolytic processing; Degradation; Dipeptidyl (amino)peptidase; Prolyl endopeptidase 1. INTRODUCTION 2. DIRECTION OF THE PROTEOLYTIC MATURATION OF REGULATORY The unique cyclic and imino structure of the PEPTIDES BY PROLINE RESIDUES amino acid proline influences not only the confor- mation of peptide chains, but also restricts the at- Regulatory peptides are synthesized as part of tack of proteases.
    [Show full text]
  • How Metal Cofactors Drive Dimer–Dodecamer Transition of the M42 Aminopeptidase Tmpep1050 of Thermotoga Maritima
    This is a repository copy of How metal cofactors drive dimer–dodecamer transition of the M42 aminopeptidase TmPep1050 of Thermotoga maritima. White Rose Research Online URL for this paper: http://eprints.whiterose.ac.uk/159066/ Version: Accepted Version Article: Dutoit, R, Van Gompel, T, Brandt, N et al. (4 more authors) (2019) How metal cofactors drive dimer–dodecamer transition of the M42 aminopeptidase TmPep1050 of Thermotoga maritima. Journal of Biological Chemistry, 294 (47). pp. 17777-17789. ISSN 0021-9258 https://doi.org/10.1074/jbc.ra119.009281 © 2019 Dutoit et al. Published under exclusive license by The American Society for Biochemistry and Molecular Biology, Inc. This is an author produced version of a paper published in Journal of Biological Chemistry. Uploaded in accordance with the publisher's self-archiving policy. Reuse Items deposited in White Rose Research Online are protected by copyright, with all rights reserved unless indicated otherwise. They may be downloaded and/or printed for private study, or other acts as permitted by national copyright laws. The publisher or other rights holders may allow further reproduction and re-use of the full text version. This is indicated by the licence information on the White Rose Research Online record for the item. Takedown If you consider content in White Rose Research Online to be in breach of UK law, please notify us by emailing [email protected] including the URL of the record and the reason for the withdrawal request. [email protected] https://eprints.whiterose.ac.uk/
    [Show full text]
  • SI Table 1. Assessment of Genome Completeness
    SI Table 1. Assessment of Genome Completeness COG family IMG gene object identifier Conserved gene set Large subunit ribosomal proteins COG0081 2062288324 Ribosomal protein L1 COG0244 2062347387 Ribosomal protein L10 COG0080 2062288323 Ribosomal protein L11 COG0102 Absent Ribosomal protein L13 COG0093 2062418832 Ribosomal protein L14 COG0200 2062418826 Ribosomal protein L15 COG0197 2062418838 Ribosomal protein L16/L10E COG0203 2062418836 Ribosomal protein L17 COG0256 2062418829 Ribosomal protein L18 COG0335 2062273558 Ribosomal protein L19 COG0090 2062418842 Ribosomal protein L2 COG0292 2062350539 Ribosomal protein L20 COG0261 2062142780 Ribosomal protein L21 COG0091 2062418840 Ribosomal protein L22 COG0089 2062138283 Ribosomal protein L23 COG0198 2062418834 Ribosomal protein L24 COG1825 2062269715 Ribosomal protein L25 (general stress protein Ctc) COG0211 2062142779 Ribosomal protein L27 COG0227 Absent Ribosomal protein L28 COG0255 2062418837 Ribosomal protein L29 COG0087 2062154483 Ribosomal protein L3 COG1841 2062335748 Ribosomal protein L30/L7E COG0254 Absent Ribosomal protein L31 COG0333 Absent Ribosomal protein L32 COG0267 Absent Ribosomal protein L33 COG0230 Absent Ribosomal protein L34 COG0291 2062350538 Ribosomal protein L35 COG0257 Absent Ribosomal protein L36 COG0088 2062138282 Ribosomal protein L4 COG0094 2062418833 Ribosomal protein L5 COG0097 2062418830 Ribosomal protein L6P/L9E COG0222 2062288326 Ribosomal protein L7/L12 COG0359 2062209880 Ribosomal protein L9 Small subunit ribosomal proteins COG0539 Absent Ribosomal protein
    [Show full text]